{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:46:24Z","timestamp":1793310384523,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cgh.2023.08.015","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T05:05:40Z","timestamp":1693717540000},"page":"252-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"22","author":[{"given":"Christopher J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1167-1101","authenticated-orcid":false,"given":"Evan S.","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.08.015_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.08.015_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cgh.2017.06.036","article-title":"Health-related quality of life and costs associated with eosinophilic esophagitis: a systematic review","volume":"16","author":"Mukkada","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/dox128","article-title":"Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis","volume":"31","author":"Stern","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.cgh.2023.08.015_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2014.02.015","article-title":"Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis","volume":"43","author":"Hirano","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2023.08.015_bib7","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC202005050","article-title":"Eosinophilic esophagitis","volume":"172","author":"Katzka","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2023.08.015_bib8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.08.015_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.gtc.2021.08.001","article-title":"Eosinophilic esophagitis: incidence, diagnosis, management, and future directions","volume":"50","author":"Fernandez-Becker","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2023.08.015_bib10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.15231","article-title":"Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"49","author":"Navarro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.08.015_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ajg.2014.316","article-title":"Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States","volume":"110","author":"Jensen","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.08.015_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.gastro.2017.05.066","article-title":"Diagnosis and treatment of eosinophilic esophagitis","volume":"154","author":"Straumann","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib13","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2020.02.038","article-title":"AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters clinical guidelines for the management of eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2014.07.055","article-title":"Advances in clinical management of eosinophilic esophagitis","volume":"147","author":"Dellon","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1053\/j.gastro.2020.02.039","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"158","author":"Rank","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib16","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.cgh.2020.01.024","article-title":"Efficacy of therapy for eosinophilic esophagitis in real-world practice","volume":"18","author":"Laserna-Mendieta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2021.05.049","article-title":"Long-lasting dissociation of esophageal eosinophilia and symptoms after dilation in adults with eosinophilic esophagitis","volume":"20","author":"Safroneeva","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrgastro.2017.56","article-title":"Management of refractory eosinophilic oesophagitis","volume":"14","author":"Dellon","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2014.07.034","article-title":"Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients","volume":"13","author":"Wolf","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dld.2022.03.006","article-title":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","volume":"54","author":"Thakkar","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2023.08.015_bib21","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-017-4642-7","article-title":"Six-food elimination diet and topical steroids are effective for eosinophilic esophagitis: a meta-regression","volume":"62","author":"Cotton","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.08.015_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2019.10.027","article-title":"Emerging therapies for eosinophilic esophagitis","volume":"145","author":"Greuter","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.cgh.2023.08.015_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib24","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.08.015_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2022.01.019","article-title":"Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use","volume":"128","author":"Spergel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.cgh.2023.08.015_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000180","article-title":"Real world experience with dupilumab in eosinophilic esophagitis in children and young adults at a tertiary care pediatric medical center","volume":"3","author":"Syverson","year":"2022","journal-title":"JPGN Rep"},{"key":"10.1016\/j.cgh.2023.08.015_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MPG.0000000000003512","article-title":"A\u00a0case series on the use of dupilumab for treatment of refractory eosinophilic gastrointestinal disorders","volume":"75","author":"Patel","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2023.08.015_bib29","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000887","article-title":"Refractory pediatric fibrostenotic eosinophilic esophagitis treated with dupilumab","volume":"9","author":"Gangadharan Nambiar","year":"2022","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.cgh.2023.08.015_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000250","article-title":"Histologically remarkable eosinophilic esophagitis responsive to dupilumab in a gastrostomy tube-dependent pediatric patient on amino acid formula","volume":"3","author":"Castro","year":"2022","journal-title":"JPGN Rep"},{"key":"10.1016\/j.cgh.2023.08.015_bib31","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1097\/PG9.0000000000000273","article-title":"Relapse of eosinophilic esophagitis on dupilumab","volume":"3","author":"Buendia","year":"2022","journal-title":"JPGN Rep"},{"key":"10.1016\/j.cgh.2023.08.015_bib32","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.17554\/j.issn.2224-3992.2015.04.562","article-title":"Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis","volume":"4","author":"Wolf","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol Res"},{"key":"10.1016\/j.cgh.2023.08.015_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cgh.2017.09.046","article-title":"Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study","volume":"16","author":"Reed","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib34","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.cgh.2019.01.030","article-title":"A\u00a0conceptual approach to understanding treatment response in eosinophilic esophagitis","volume":"17","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.08.015_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cgh.2015.08.040","article-title":"Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment","volume":"14","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/a-1675-7860","article-title":"Determination of a treatment response threshold for the Eosinophilic Esophagitis Endoscopic Reference Score","volume":"54","author":"Cotton","year":"2022","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2023.08.015_bib38","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.cgh.2022.11.004","article-title":"Higher body mass index is associated with decreased treatment response to topical steroids in eosinophilic esophagitis","volume":"21","author":"Ketchem","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.dld.2021.10.004","article-title":"Older patients with eosinophilic esophagitis have high treatment response to topical steroids","volume":"54","author":"Ketchem","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2023.08.015_bib40","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1038\/ctg.2017.27","article-title":"Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis","volume":"8","author":"Eluri","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2023.08.015_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A\u00a0phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2023.08.015_bib42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.08.015_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/a-1493-5627","article-title":"Dilation-predominant approach versus routine care in patients with difficult-to-treat eosinophilic esophagitis: a retrospective comparison","volume":"54","author":"Greenberg","year":"2022","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2023.08.015_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ajg.2015.399","article-title":"Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype","volume":"111","author":"Runge","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.08.015_bib45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.gie.2015.11.019","article-title":"The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis","volume":"83","author":"Eluri","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2023.08.015_bib46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cgh.2018.09.005","article-title":"Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis","volume":"17","author":"Eluri","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.08.015_bib47","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.14309\/00000434-201310001-00037","article-title":"Predictors of non-response to topical steroids treatment in eosinophilic esophagitis","volume":"108","author":"Moawad","year":"2013","journal-title":"Am Coll Gastroenterol"},{"key":"10.1016\/j.cgh.2023.08.015_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","article-title":"Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick","volume":"130","author":"Aceves","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.cgh.2023.08.015_bib49","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/apt.14061","article-title":"A\u00a0visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis","volume":"45","author":"Reed","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.08.015_bib50","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.14309\/ajg.0000000000000957","article-title":"Dilation modifies association between symptoms and esophageal eosinophilia in adult patients with eosinophilic esophagitis","volume":"115","author":"Safroneeva","year":"2020","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523006651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523006651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:45:43Z","timestamp":1761543943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523006651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1542356523006651"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.08.015","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute","name":"copyright","label":"Copyright"}]}}